Sanjoy Dutta, Ph.D., is the Chief Scientific Officer at JDRF, the world’s largest non-profit organization funding research in type 1 diabetes (T1D) globally. He oversees all of JDRF’s efforts to cure type 1 diabetes and improve the lives of those living with it, which includes screening for risk of T1D, beta cell therapies, immunotherapies, glucose and metabolic control and complications. He is also responsible for international partnerships with world-leading government, non-government, foundation and commercial organizations, including expansion to new geographies such as the middle east. Dr. Dutta joined JDRF in 2009. Prior to coming to JDRF, Dr. Dutta was the associate director of translational medicine and clinical biomarkers at Bristol-Myers Squibb and principal scientist of cardiovascular and metabolic diseases at Hoffmann-La Roche. Dr. Dutta obtained his doctorate from the department of biochemistry and molecular biology at the University of Southern California and was a JDRF Postdoctoral Fellow in the department of cell biology and the Joslin Diabetes Center at Harvard Medical School.